SUBSCRIBE
SUBSCRIBE
News   Drug Development

GlaxoSmithKline Tests Intravenous Flu Drug vs Tamiflu

January 19, 2011 | 
1 min read
Reuters -- GlaxoSmithKline (GSK.L) has started a pivotal study testing intravenous zanamivir against Roche's (ROG.VX) best-selling pill Tamiflu as a treatment for patients hospitalised with influenza, it said on Wednesday.
Clinical research Phase 3
GSK
MORE ON THIS TOPIC
Red trend as symbol of economy drop or financial crisis. Business pattern
Drug Development
Argenx shutters Sjogren’s study, losing blockbuster expansion opportunity for Vyvgart
October 8, 2026
 · 
2 min read
 · 
Gabrielle Masson
3D Yellow triangle warning sign symbol on yellow background. Emergency alert, and caution. Illustration with copy space
Drug Development
Newron reveals 5 deaths in late-stage schizophrenia program as FDA maintains hold
October 8, 2026
 · 
2 min read
 · 
Gabrielle Masson
Personal development and self improvement in stairs metaphor - activities that develop a person capabilities, enhance quality of life and realization of dreams and aspirations
Weight loss
Despite Zealand asset’s ‘intriguing’ weight loss, analysts underwhelmed by blood sugar numbers
October 8, 2026
 · 
4 min read
 · 
Annalee Armstrong
Insights
Beyond equity: Why venture debt is reshaping European biotech
October 8, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker